What is primary hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Primary Hyperparathyroidism?

Primary hyperparathyroidism (PHPT) is a disorder in which one or more parathyroid glands autonomously overproduce parathyroid hormone (PTH), typically resulting in hypercalcemia. 1

Pathophysiology and Etiology

  • PHPT occurs when parathyroid glands excessively secrete PTH independent of normal regulatory feedback mechanisms, leading to elevated serum calcium levels 1, 2
  • A single benign parathyroid adenoma causes approximately 80% of all PHPT cases 1, 3
  • Multigland disease (multiple adenomas or hyperplasia) accounts for 15-20% of cases 1
  • Parathyroid carcinoma is rare, occurring in less than 1% of cases 1
  • Most cases are sporadic, though hereditary forms exist including multiple endocrine neoplasia types 1 and 2A, as well as familial hyperparathyroidism 1

Biochemical Hallmark and Diagnosis

The diagnosis of PHPT is established biochemically by demonstrating hypercalcemia (or high-normal calcium) with elevated or inappropriately normal PTH levels. 4, 5

Diagnostic Criteria:

  • Measure serum calcium (corrected for albumin) and intact PTH simultaneously 4
  • Hypercalcemia with normal or elevated PTH is diagnostic 3
  • Serum phosphate is typically low or low-normal 4
  • Imaging has no utility in confirming or excluding the diagnosis of PHPT—it is used solely for preoperative localization 1, 3

Important Diagnostic Considerations:

  • Assess 25-hydroxyvitamin D levels, as vitamin D deficiency can complicate PTH interpretation 3, 4
  • Measure serum creatinine to evaluate kidney function 4
  • A 24-hour urine collection for calcium and other metabolites helps evaluate complications 4

Clinical Presentation Spectrum

Geographic Variation in Presentation:

  • In countries with routine biochemical screening (United States, Canada, most of Europe), PHPT predominantly presents as asymptomatic hypercalcemia 1, 2
  • In countries without routine screening (China, India), PHPT typically presents with symptomatic target organ involvement 1

Symptomatic Manifestations:

  • Bone demineralization and pathologic fractures 1
  • Nephrolithiasis and nephrocalcinosis 1, 6
  • Muscle weakness 1
  • Neurocognitive disorders 1
  • Pancreatitis (less common) 6

Normocalcemic Variant:

  • A forme fruste variant exists where serum calcium remains persistently normal but PTH is consistently elevated without an obvious secondary cause 2, 7

Epidemiology

  • PHPT is more common in women, with an incidence of 66 per 100,000 person-years compared to 25 per 100,000 person-years in men 1
  • The prevalence appears to be increasing significantly 1
  • PHPT is uncommon in children, with an estimated incidence of 2-5 cases per 100,000 persons 6

Clinical Significance and Complications

  • PHPT is recognized as a secondary cause of hypertension in major cardiovascular guidelines 8, 3
  • Long-term hypercalcemia can lead to persistent hypertension, kidney stones, bone disease, and other complications 8, 3
  • Patients with 24-hour urine calcium >400 mg/day are at increased risk for kidney stone formation and bone complications 4

Treatment Approach

Surgical excision of the abnormally functioning parathyroid tissue is the definitive curative treatment and is typically indicated even when asymptomatic, given the potential negative effects of long-term hypercalcemia. 1, 8, 3

Surgical Options:

  • Minimally invasive parathyroidectomy (MIP) requires confident preoperative localization of a single adenoma and offers shorter operating times, faster recovery, and decreased costs 1
  • Bilateral neck exploration (BNE) remains necessary for discordant/nonlocalizing imaging or high suspicion for multigland disease 1

Preoperative Localization Imaging:

  • First-line imaging includes ultrasound and 99mTc-sestamibi scintigraphy with SPECT/CT 3, 4
  • 4D-CT (noncontrast, arterial, and venous phases) may be useful for reoperative cases or suspected ectopic glands 3, 4
  • Remember: imaging is performed solely for surgical planning, not for diagnosis 3, 4

Common Pitfalls to Avoid

  • Do not use imaging to diagnose PHPT—diagnosis is biochemical only 1, 3
  • Always assess vitamin D status before interpreting PTH levels, as deficiency can mask the diagnosis 4
  • Be aware that different PTH assay generations measure different PTH fragments and lack standardization between laboratories 4
  • Biotin supplements can interfere with PTH assays 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Primary hyperparathyroidism.

Nature reviews. Disease primers, 2016

Guideline

Primary Hyperparathyroidism due to Superior Parathyroid Adenoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Primary Hyperparathyroidism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperparathyroidism: primary or secondary disease?

Reumatologia clinica, 2012

Research

Three pediatric patients with primary hyperparathyroidism caused by parathyroid adenoma.

Annals of pediatric endocrinology & metabolism, 2022

Research

Normocalcemic primary hyperparathyroidism.

Arquivos brasileiros de endocrinologia e metabologia, 2010

Guideline

Parathyroid Adenoma and Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the implications and management options for a patient with chronic suppressed Thyroid-Stimulating Hormone (TSH) and normal free Thyroxine (T4), who now presents with elevated Parathyroid Hormone (PTH) and normal calcium levels?
What test can confirm primary hyperparathyroidism?
How do you make a differential diagnosis between primary, secondary, and tertiary hyperparathyroidism in patients with suspected hyperparathyroidism?
What is the cause of hypercalcemia with decreased Parathyroid Hormone (PTH) and elevated Parathyroid Hormone-related Protein (PTHrP)?
What laboratory finding is expected in a child with high Parathyroid Hormone (PTH) levels and bone pain?
What is the definition, causes, clinical features, investigation, and management of acute gastroenteritis in children, particularly those under 6 months old, according to the Indian Academy of Pediatrics (IAP) guidelines?
What is the role of ARMC5 (Armadillo Repeat-Containing 5) molecular biology in the management of a patient with primary macronodular adrenal hyperplasia (PMAH) and a family history of the condition?
What dose of quetiapine can be given to an adult patient with a history of psychiatric illness, who has received 3 doses of Acuphase in the last 6 days, to manage acute agitation?
What is the recommended treatment for severe itching in a patient with Diabetes Mellitus (DM), considering the potential impact on blood sugar levels, and is a triamcinolone (corticosteroid) injection a suitable option?
What is the recommended daily dose of lorazepam for an adult patient with alcohol use disorder, recently treated with Acuphase (acamprosate), to manage agitation?
How does ethnicity clustering impact the management of primary macronodular adrenal hyperplasia (PMAH) in patients with a family history of the condition and potential ARMC5 (Armadillo Repeat-Containing 5) mutations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.